Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline Is Regulated by Different Cancer Stem Cell Populations

  • Jo Meagan Garner,
  • David W. Ellison,
  • David Finkelstein,
  • Debolina Ganguly,
  • Ziyun Du,
  • Michelle Sims,
  • Chuan He Yang,
  • Rodrigo B. Interiano,
  • Andrew M. Davidoff,
  • Lawrence M. Pfeffer

Fig 5 is incorrect. There are duplicated panels. The authors have provided a corrected version here.

thumbnail
Download:
Fig 5. Pathologic analysis of orthotopic GBM6 tumor xenografts.

GBM6 bulk tumor cells, Ad-GSCs and Sp-GSCs were orthotopically injected as described in Fig 4, and tumor-bearing brains were paraffin embedded for histology. A. H&E staining and B. Immunoreactivity for GFAP, S100, OLIG2 and MAP2. (All photomicrographs taken at 200x).

https://doi.org/10.1371/journal.pone.0145052.g001

Reference

  1. 1. Garner JM, Ellison DW, Finkelstein D, Ganguly D, Du Z, Sims M, et al. (2015) Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline Is Regulated by Different Cancer Stem Cell Populations. PLoS ONE 10(5): e0125838. pmid:25955030

Citation: Garner JM, Ellison DW, Finkelstein D, Ganguly D, Du Z, Sims M, et al. (2015) Correction: Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline Is Regulated by Different Cancer Stem Cell Populations. PLoS ONE 10(12): e0145052. https://doi.org/10.1371/journal.pone.0145052

Published: December 10, 2015

Copyright: © 2015 Garner et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited